How do anticoagulants interact with targeted therapies in metastatic cancers, and what are the implications for patient outcomes?
Gaurav ChauhanContributor
How do anticoagulants interact with targeted therapies in metastatic cancers?
Share
Anticoagulants may increase bleeding risks when used with targeted therapies in metastatic cancer, potentially complicating treatment and affecting patient survival outcomes.